Ventilatory Functions, Oxygen Saturation, and Quality of Life Response to Long Time Cement Dust Exposure

September 11, 2021 updated by: Ramy Salama Draz, Cairo University
Thousands of people are working daily in a dusty environment. Many studied reported respiratory symptoms and ventilatory disorders among Factory workers who exposed to cement dust. But the evidence for respiratory effect and daily activities over a long time of cement dust exposure has not been conclusive

Study Overview

Detailed Description

A total of 49 subjects working in a cement production factory were assessed and divided into three groups according to the total period of work exposure. Groupe A (18 subjects) with work period < 10 years, group B (13 subjects) with work period 10-15 years, group C (18 subjects) with work period > 15 years. The ventilatory functions, oxygen saturation, and quality of life were assessed in the three groups. RESULTS: The study results revealed a statistically significant difference between the three groups in the mean values of FVC (%), FEV1/FVC (%), SPO2.

Study Type

Observational

Enrollment (Actual)

49

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Faculty of Physical Therapy Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 50 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Male

Sampling Method

Probability Sample

Study Population

Out of sixty persons who were assigned to this study, a total of 49 subjects (group 1 n = 18, group 2 n = 13 and group 3 n = 18) completed the study (Fig. 1).

In all groups, A, B and, C; height and weight scale were obtained for calculating BMI. The distribution of smokers between different age groups was measured (table ) The pulmonary function tests were performed to evaluate the capacity and volume of the lungs among the participants. Spirometry measurements, including FVC, FEV1, ratio of FEV1 to FVC (FEV1/FVC), forced expiratory flow 25-75% (FEF 25-75%), and peak expiratory flow (PEF

Description

Inclusion Criteria:

  • The ages were between 25 to 50 years old.
  • the body mass index ranged from (18,5 - 29,9) kg/m2.

Exclusion Criteria:

  • Age less than 25 or more 50.
  • Any chronic diseases
  • severe musculoskeletal and cardiopulmonary disorders and
  • Class III Obesity (35-39.9 kg/m 2) or more

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
less than 10 years working
workers who work in cement factories in a period of time less than 10 years
we assessed the arterial blood gases and the ventilatory functions and quality of life of whole three groups
from 10-15 years working
workers who work in cement factories in a period of time from 10-15 years
we assessed the arterial blood gases and the ventilatory functions and quality of life of whole three groups
more than 15 years working
workers who work in cement factories in a period of time more than 15 years
we assessed the arterial blood gases and the ventilatory functions and quality of life of whole three groups

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The ventilatory functions
Time Frame: 8 months
ventilatory function tests were used to assess FVC (%), FEV1/FVC (%),PEF (%), FEV1 (%)
8 months
oxygen saturation
Time Frame: 8 months
measuring oxygen saturation using SPo2
8 months
quality of life were assessed
Time Frame: 8 months
the mean values of the physical functioning item and energy/fatigue item in the quality of life questionnaire
8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

March 5, 2019

Study Completion (Actual)

May 29, 2019

Study Registration Dates

First Submitted

September 4, 2020

First Submitted That Met QC Criteria

September 11, 2021

First Posted (Actual)

September 17, 2021

Study Record Updates

Last Update Posted (Actual)

September 17, 2021

Last Update Submitted That Met QC Criteria

September 11, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Cairo

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Occupational Diseases

Clinical Trials on questionaire and ventilatory function test

Subscribe